Beam Therapeutics Inc., a biotechnology company specializing in precision genetic medicines through base editing, will participate in a fireside chat at the 2025 RBC Capital Markets Global Healthcare Conference. The event is scheduled for Tuesday, May 20, 2025, at 11:00 a.m. ET in New York.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Beam Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9448565-en) on May 13, 2025, and is solely responsible for the information contained therein.